Outsourcing

Jul 24, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
The API and drug product provider will invest £375,000 (US$493,000) in additional nuclear magnetic resonance (NMR) instrumentation at its headquarters in Craigavon, UK.
Jul 23, 2018
By Pharmaceutical Technology Editors
The acquisition will place Cambrex into the finished dosage form CDMO market.
Jul 18, 2018
By Pharmaceutical Technology Editors
CELLforCURE will produce cancer CAR-T treatments for Novartis at a manufacturing facility in Les Ulis (Essonne), France.
Jul 03, 2018
By Pharmaceutical Technology Editors
Catalent’s acquisition of Juniper Pharmaceuticals further expands its early development capabilities.
Jul 02, 2018
Pharmaceutical Technology
This article highlights 15 years of changes in biopharmaceutical manufacturing.
Jul 02, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
The company expanded its extended workbench laboratory services program to support the ongoing manufacturing and development of Flexion Therapeutics’s Zilretta (triamcinolone acetonide extended-release injectable suspension).
Jun 25, 2018
By Pharmaceutical Technology Editors
Minakem’s facility in Belgium enhances capacity to scale production of highly potent ingredients for small to full GMP batches.
Jun 21, 2018
By Pharmaceutical Technology Editors
The contract development and manufacturing company has received an additional approval from Health Canada to manufacture monoclonal antibody drug substance at its first plant in Icheon, South Korea.
Jun 19, 2018
By Pharmaceutical Technology Editors
WuXi STA supported the development of hepatitis drug through marketing authorization holder pilot program.
Jun 14, 2018
By Pharmaceutical Technology Editors
Recipharm adds inhalation drug manufacturing capacity with the acquisition of Sanofi’s Holmes Chapel, UK site.
native1_300x100
lorem ipsum